Cohance Lifesciences is not just a brand it’s a culmination of vision, scientific ambition, and purposeful integration. Our story began with a series of intentional moves, starting with the acquisition of RA Chem Pharma.  Over time, a deliberate series of mergers and acquisitions including ZCL Chemicals, Avra Laboratories, Suven Pharmaceuticals, Sapala Organics, and NJ Bio brought together differentiated capabilities in Pharma CDMO, APIs, Specialty Chemicals, Formulations, and next-gen platforms like ADCs and Oligonucleotides.